25 Mar 2015
Industrial-academic partnership between M-Squared Lasers and St Andrews University designed to aid medical research into cancer and Alzheimer’s disease.
Targeting disease: the M Squared and St Andrews team get set.
The newly-signed IPR Technology Transfer Agreement covers a broad portfolio of more than 100 patents, which researchers will use to develop commercial applications for the health sector. The patents cover microfluidics, particle fractionation and sorting, optical tweezing, cell poration, imaging and Raman spectroscopic analysis techniques.Professor Kishan Dholakia at the University of St Andrews commented, “One key area we’ll be exploring is the use of Raman light-scattering which can be used in the fight against cancer by distinguishing between normal and unhealthy cells and tissue. In a similar way, Raman coupled with the use of fluorescence techniques, may be used in the area of authentication of high value liquors and spirits.
“More broadly we’ll be looking to unlock new information about how the human brain works. Through the use of advanced compact imaging platforms, which minimize damage through laser exposure, we hope to highlight cellular processes that could lead to an improved understanding of neural networks and conditions such as Alzheimer’s disease.
“While we’re becoming more adept at developing lasers with higher specifications and quality, we still need to continually improve the way we characterize their performance, which is another area of research included in this suite of licensed technology.”
The partners say the new deal is projected to bring “seven figure returns” to both the University of St Andrews and M Squared Lasers over the period of commercialization of the technologies. Both parties are now looking to engage with approaches for applications of biophotonics technology from other companies wordwide.
Dr Graeme Malcolm OBE, CEO of M Squared Lasers said, “This new partnership presents the opportunity to match our existing knowledge with relevant academic research, something which we hope will lead to significant developments for the health sector.
Professor Kishan Dholakia, added, “This is an exciting technology transfer opportunity for the University’s biophotonics portfolio and stems from many years of interaction between M Squared Lasers and several research professors in the School of Physics and Astronomy. My researcher colleagues and I are looking forward to working with M Squared Lasers to ensure that exciting new products will be developed.”
The Biophotonics Licence Agreement follows three other such commercialisation agreements between the University of St Andrews and M Squared Lasers. Last year, the University of St Andrew’s licensed its ultrafast laser and fast pulse autocorrelation patents and further assigned its patent family of multiple strands of IPR in the areas of mid-infrared optical parametric oscillator and terahertzz technologies, used in the company’s Firefly gas imaging and security product ranges.
About the Author
Matthew Peach is contributing editor to optics.org.
|Nano-particles help US Naval Research Lab build powerful lasers|
|Japanese group to trial electric cars fitted with ‘solar batteries’|
|Nanostructures free photons to boost white OLED efficiency|
|Lumedica looks to fine-tune low-cost OCT system with SBIR grant|
|Sub-sea 3D laser camera readied for commercial introduction|
|Novel materials enable VIS-IR-sensitive solar cells|